利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

262 条记录 (耗时 0.039 秒)

    Method of screening a therapeutic agent for therapeutic effectiveness
    26.
    发明公开
    Method of screening a therapeutic agent for therapeutic effectiveness 审中-公开
    的治疗剂的筛选方法以确定其有效性

    公开(公告)号：EP2275959A3

    公开(公告)日：2011-04-06

    申请号：EP10183881.1

    申请日：2002-07-11

    申请人： CNS Response, Inc.

    发明人： Suffin, Stephen ,  Emory, Hamlin W. ,  Brand, Leonard J.

    IPC分类号： G06F19/00 ,  A61B5/04

    CPC分类号： A61B5/4076 ,  A61B5/0006 ,  A61B5/0476 ,  A61B5/411 ,  A61B5/4833 ,  A61B5/7257 ,  A61B5/7264 ,  G06F19/00 ,  G06F19/3481 ,  G16H15/00 ,  G16H50/20 ,  G16H50/70

    摘要： The present invention relates to a method of screening a therapeutic agent for therapeutic effectiveness, comprising:
    a) providing:
    i) at least one patient, wherein said patient has a first disorder associated with a first set of electroencephalographic information;
    ii) a plurality of reference patients comprising at least one second disorder associated with a second set of electroencephalographic information;
    iii) a therapeutic agent, wherein said agent has no known therapeutic effectiveness for said at least one second disorder; and

    b) treating said patient with said agent, wherein said agent is therapeutically effective for said first disorder;
    c) identifying, using a computer a similarity between said first set of electroencephalographic information and said second set of electroencephalographic information; and d. indicating said agent as having therapeutic effectiveness for said at least one second disorder based upon said similarity in said reference patients.

    Method of screening a therapeutic agent for therapeutic effectiveness
    27.
    发明公开
    Method of screening a therapeutic agent for therapeutic effectiveness 审中-公开
    筛选 - Verfahren eines therapeutischen Mittels zur Bestimmung seiner Wirksamkeit

    公开(公告)号：EP2275959A2

    公开(公告)日：2011-01-19

    申请号：EP10183881.1

    申请日：2002-07-11

    申请人： CNS Response, Inc.

    发明人： Suffin, Stephen ,  Emory, Hamlin W. ,  Brand, Leonard J.

    IPC分类号： G06F19/00 ,  A61B5/04

    CPC分类号： A61B5/4076 ,  A61B5/0006 ,  A61B5/0476 ,  A61B5/411 ,  A61B5/4833 ,  A61B5/7257 ,  A61B5/7264 ,  G06F19/00 ,  G06F19/3481 ,  G16H15/00 ,  G16H50/20 ,  G16H50/70

    摘要： The present invention relates to a method of screening a therapeutic agent for therapeutic effectiveness, comprising:
    a) providing:
    i) at least one patient, wherein said patient has a first disorder associated with a first set of electroencephalographic information;
    ii) a plurality of reference patients comprising at least one second disorder associated with a second set of electroencephalographic information;
    iii) a therapeutic agent, wherein said agent has no known therapeutic effectiveness for said at least one second disorder; and

    b) treating said patient with said agent, wherein said agent is therapeutically effective for said first disorder;
    c) identifying, using a computer a similarity between said first set of electroencephalographic information and said second set of electroencephalographic information; and d. indicating said agent as having therapeutic effectiveness for said at least one second disorder based upon said similarity in said reference patients.

    摘要翻译： 本发明涉及一种筛选用于治疗有效性的治疗剂的方法，包括：a）提供：i）至少一名患者，其中所述患者具有与第一组脑电图信息相关的第一种病症; ii）多个参考患者，包括与第二组脑电图信息相关联的至少一种第二病症; iii）治疗剂，其中所述药剂对于所述至少一种第二种病症没有已知的治疗有效性; 和b）用所述药物治疗所述患者，其中所述药剂对于所述第一种病症是治疗有效的; c）使用计算机识别所述第一组脑电图信息和所述第二组脑电图信息之间的相似性; 和d。 指示所述试剂基于所述参考患者的所述相似性具有对所述至少一种第二病症的治疗有效性。